Abbott Laboratories Aktie

Abbott Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 850103 / ISIN: US0028241000

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
17.07.2025 13:37:46

Abbott Laboratories Q2 Profit Increases, Beats Estimates

(RTTNews) - Abbott Laboratories (ABT) announced a profit for its second quarter that Increased from last year and beat the Street estimates.

The company's bottom line totaled $1.779 billion, or $1.01 per share. This compares with $1.302 billion, or $0.74 per share, last year.

Excluding items, Abbott Laboratories reported adjusted earnings of $2.213 billion or $1.26 per share for the period.

Analysts on average had expected the company to earn $1.25 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 7.4% to $11.142 billion from $10.377 billion last year.

Abbott Laboratories earnings at a glance (GAAP) :

-Earnings: $1.779 Bln. vs. $1.302 Bln. last year. -EPS: $1.01 vs. $0.74 last year. -Revenue: $11.142 Bln vs. $10.377 Bln last year.

-Guidance: Next quarter EPS guidance: $1.28 to $1.32. Full year EPS guidance: $5.10 to $5.20

Analysen zu Abbott Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Abbott Laboratories 114,74 1,40% Abbott Laboratories